Experiences with dose finding in patients in early drug development: the use of biomarkers in early decision making.

Ernst Schering Research Foundation workshop

Volumn , Issue 59, 2007, Pages 65-79

  Sultana, S R ^a   Marshall, S ^a   Davis, J ^a   Littman, B H ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHENYLEPHRINE;

BLOOD PRESSURE; CHEMISTRY; COMPUTER; DECISION MAKING; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; EQUIPMENT DESIGN; HUMAN; IMPOTENCE; MALE; PATHOLOGY; PRESSURE; REVIEW; URETHRA; UROGENITAL SYSTEM;

BIOLOGICAL MARKERS; BLOOD PRESSURE; COMPUTERS; DECISION MAKING; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; EQUIPMENT DESIGN; HUMANS; IMPOTENCE; MALE; PHENYLEPHRINE; PRESSURE; URETHRA; UROGENITAL SYSTEM;

MLCS; MLOWN;

EID: 34247392807     PISSN: 09476075     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-540-49529-1_5     Document Type: Review

References (13)